Press Releases from http://www.marketresearchreports.biz/analysis/187245 (1 total)
Biosimilars - The Future Transformation Of Product Exclusivity In The Biotechnol …
The nature of biotechnology has, up until recently, prevented the threat of generic intrusion on product sales. Biologics are difficult to replicate compared to small molecules and even slight differences in manufacturing processes could lead to significant clinical differences.
The US government is poised to address the need for a process by which similar biologics or proteins can be approved and brought to market. Two legislations are on the table, one…
